Why did Yiling Pharmaceutical's innovative traditional Chinese medicine get the evaluation of "Beijing Evening News readers recommended family standing cough medicine"?

Beijing Evening News has been held for 12 years, with strong credibility and wide influence, which has won wide attention and praise from readers and become the "wind vane" in the field of family standing drugs. Lianhua Qingke Tablet is an innovative Chinese medicine developed by Ling Pharmaceutical under the guidance of collateral disease theory of traditional Chinese medicine. Included in the national medical insurance catalogue. It has the functions of "dispersing lung, clearing heat, resolving phlegm and relieving cough", which is helpful to reduce sputum production, reduce sputum viscosity and promote sputum discharge. At the same time, it also has the functions of protecting airway mucosa, relieving airway spasm, improving airway resistance, reducing lung injury caused by repeated episodes of airway inflammation and relieving cough. In view of the systematic study of acute bronchitis, chronic bronchitis and other respiratory infectious diseases, Lianhua Qingke Tablet has formed a scientific evidence chain of theory, practice and evidence. Based on the exact clinical efficacy and scientific evidence, Lianhua Qingke Tablet has been recommended by national, provincial and municipal diagnosis and treatment projects for more than 30 times since it was approved for listing in May 2020, and has been approved for registration in Singapore, Nigeria and other countries.